State Of Wisconsin Investment Board Next Cure, Inc. Transaction History

State Of Wisconsin Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$7.6 - $10.28 $150,480 - $203,544	-19,800 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.81 - $13.88 $227,592 - $322,016	-23,200 Reduced 53.95%	19,800 $198,000
Q4 2020 Feb 03, 2021	SELL	$9.47 - $12.43 $169,513 - $222,497	-17,900 Reduced 29.39%	43,000 $469,000
Q3 2020 Nov 16, 2020	BUY	$8.15 - $21.17 $290,140 - $753,652	35,600 Added 140.71%	60,900 $536,000
Q2 2020 Aug 12, 2020	BUY	$21.19 - $40.2 $63,570 - $120,600	3,000 Added 13.45%	25,300 $542,000
Q1 2020 May 06, 2020	BUY	$32.32 - $58.37 $578,528 - $1.04 Million	17,900 Added 406.82%	22,300 $827,000
Q4 2019 Feb 14, 2020	BUY	$25.0 - $92.22 $110,000 - $405,768	4,400 New	4,400 $248,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.